Who is sponsoring NCT01567657?

NCT01567657 is sponsored by Kantonsspital Münsterlingen.

What condition does NCT01567657 study?

NCT01567657 studies Hypotension.

What drugs are being tested in NCT01567657?

Interventions: pethidin hydrochlorid, midazolam, Propofol.

What is the status of NCT01567657?

NCT01567657 is currently COMPLETED.

Last reviewed 2013-01-25 · How we verify

Phase II Study of Comparison of Two Sedation Regimen for Transesophageal Echocardiography in Point of View of Blood Pressure Response, Safety and Patient Comfort

NCT01567657 Phase 2 COMPLETED

The purpose of this study is to determine whether sedation with a combination of pethidin hydrochlorid plus midazolam intravenously (i.v.) is superior to propofol i.v. alone in relation to blood pressure drops during an transesophageal echocardiographic examination (TEE).

Details

Lead sponsor	Kantonsspital Münsterlingen
Phase	Phase 2
Status	COMPLETED
Enrolment	200
Start date	2012-01
Completion	2013-01

Conditions

Hypotension

Interventions

pethidin hydrochlorid, midazolam
Propofol

Primary outcomes

Number of patients with a blood pressure drop of more than 30 mmHg and below 100 mmHg systolic — During examination (TEE), expected to be ca. 30 minutes

Countries

Switzerland